The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy

Click to increase image sizeClick to decrease image size

Acknowledgements

Medical writing/Editorial assistance: The article was written by the main author; no other services and Editorial assistance were needed.

Prior publication: This manuscript is not based on work that has been previously presented/published.

Author contributions

Jarmila Čelakovská: selection of the patients, dermatological examination and recommendations for the laboratory examination; processing of all results; writing of the manuscript. Eva Čermáková: statistical analysis. Ctirad Andrýs – control of laboratory examination. Petra Boudkova: laboratory examination and flow cytometry. Jan Krejsek: professional cooperation and supervision.

Ethics statement

This study was approved by Ethics Committee of the Faculty Hospital Hradec Králové, Charles University of Prague, Czech Republic. Reference number is: 2021 10 P 03. The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board – Ethics Committee of the Faculty Hospital Hradec Králové, Charles University of Prague, Czech Republic. Data of Approval 4 September 2021.

Consent form

Informed consent was obtained from all subjects involved in the study.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Additional information

Funding

This work was supported by the Charles University, Medical Faculty Hradec Králové, Cooperation, INDI 207034 (the financial support was intended for research purposes to examine the immunological profile). The Service Fee was funded by the authors.